Extracellular calcium promotes the migration of breast cancer cells through the activation of the calcium sensing receptor - PubMed

Affiliations

• PMID: 19285978
• DOI: 10.1016/j.yexcr.2009.03.003

Extracellular calcium promotes the migration of breast cancer cells through the activation of the calcium sensing receptor

Zuzana Saidak et al. Exp Cell Res. 2009.

Abstract

Breast cancer is the most frequent form of cancer in women, with the highest incidence of metastasis to the bone. The reason for the preferential destination to the bone is believed to be due to chemoattractant factors released during bone resorption, which act on the cancer cells facilitating their metastasis. One of the factors released during osteolysis that may mediate breast cancer bone localization is Ca2+. Here, we show that extracellular Ca2+ (Ca2+(o)) acting via the calcium-sensing receptor (CaSR), greatly promotes the migration of bone-preferring breast cancer cells. In Boyden Chamber and Scratch Wound migration assays, an increase in breast cancer cell migration was observed at 2.5 mM and 5 mM Ca2+(o) compared to basal levels for three of the four breast cancer cell lines tested. However, a significantly greater migratory response was observed for the highly bone metastatic MDA-MB-231 cells, compared to the MCF7 and T47D, which have a lower metastatic potential in vivo. The BT474 cells, which do not metastasize to the bone, did not respond to elevated concentrations of Ca2+(o) in the migration assays. Inhibition of either ERK1/2 MAPK or phospholipase Cbeta (PLCbeta) led to an abolition of the Ca2+(o)-induced migration, implicating these pathways in the migratory response. Knockdown of the CaSR by siRNA resulted in an inhibition of the Ca2+(o)-induced migration, demonstrating the involvement of this receptor in the effect. These results suggest that the activation of the CaSR by elevated Ca2+(o) concentrations, such as those found near resorbing bone, produces an especially strong chemoattractant effect on bone metastatic breast cancer cells toward the Ca2+-rich environment.

Similar articles

• Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis.

  Liao J, Schneider A, Datta NS, McCauley LK. Liao J, et al. Cancer Res. 2006 Sep 15;66(18):9065-73. doi: 10.1158/0008-5472.CAN-06-0317. Cancer Res. 2006. PMID: 16982748

• Activation of choline kinase by extracellular Ca2+ is Ca(2+)-sensing receptor, Galpha12 and Rho-dependent in breast cancer cells.

  Huang C, Hydo LM, Liu S, Miller RT. Huang C, et al. Cell Signal. 2009 Dec;21(12):1894-900. doi: 10.1016/j.cellsig.2009.08.004. Epub 2009 Aug 27. Cell Signal. 2009. PMID: 19716891

• Calbindin-D28k and calcium sensing receptor cooperate in MCF-7 human breast cancer cells.

  Parkash J, Chaudhry MA, Rhoten WB. Parkash J, et al. Int J Oncol. 2004 May;24(5):1111-9. Int J Oncol. 2004. PMID: 15067332

• Roles for the calcium sensing receptor in primary and metastatic cancer.

  Manning AT, O'Brien N, Kerin MJ. Manning AT, et al. Eur J Surg Oncol. 2006 Sep;32(7):693-7. doi: 10.1016/j.ejso.2006.03.047. Epub 2006 Jun 9. Eur J Surg Oncol. 2006. PMID: 16765016 Review.

• Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases.

  Siclari VA, Guise TA, Chirgwin JM. Siclari VA, et al. Cancer Metastasis Rev. 2006 Dec;25(4):621-33. doi: 10.1007/s10555-006-9023-1. Cancer Metastasis Rev. 2006. PMID: 17165131 Review.

Cited by

• Calcium-sensing receptor (CaSR) promotes development of bone metastasis in renal cell carcinoma.

  Frees S, Breuksch I, Haber T, Bauer HK, Chavez-Munoz C, Raven P, Moskalev I, D Costa N, Tan Z, Daugaard M, Thüroff JW, Haferkamp A, Prawitt D, So A, Brenner W. Frees S, et al. Oncotarget. 2018 Mar 2;9(21):15766-15779. doi: 10.18632/oncotarget.24607. eCollection 2018 Mar 20. Oncotarget. 2018. PMID: 29644008 Free PMC article.

• Inhibition of gap junction channel attenuates the migration of breast cancer cells.

  Zhao K, Wang W, Guan C, Cai J, Wang P. Zhao K, et al. Mol Biol Rep. 2012 Mar;39(3):2607-13. doi: 10.1007/s11033-011-1013-x. Epub 2011 Jun 15. Mol Biol Rep. 2012. PMID: 21674188

• Ion Channels, Transporters, and Sensors Interact with the Acidic Tumor Microenvironment to Modify Cancer Progression.

  Boedtkjer E. Boedtkjer E. Rev Physiol Biochem Pharmacol. 2022;182:39-84. doi: 10.1007/112_2021_63. Rev Physiol Biochem Pharmacol. 2022. PMID: 34291319 Review.

• Calcium-sensing receptor modulates cell adhesion and migration via integrins.

  Tharmalingam S, Daulat AM, Antflick JE, Ahmed SM, Nemeth EF, Angers S, Conigrave AD, Hampson DR. Tharmalingam S, et al. J Biol Chem. 2011 Nov 25;286(47):40922-33. doi: 10.1074/jbc.M111.265454. Epub 2011 Oct 3. J Biol Chem. 2011. PMID: 21969374 Free PMC article.

• Association of calcium sensing receptor polymorphisms at rs1801725 with circulating calcium in breast cancer patients.

  Wang L, Widatalla SE, Whalen DS, Ochieng J, Sakwe AM. Wang L, et al. BMC Cancer. 2017 Aug 2;17(1):511. doi: 10.1186/s12885-017-3502-3. BMC Cancer. 2017. PMID: 28764683 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Elsevier Science
  • Ovid Technologies, Inc.

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal